This content is machine translated Atopic dermatitis in childhood and adolescence Dupilumab proves itself in daily practice In the “BioDay Registry” study, treatment with dupilumab in pediatric patients with atopic dermatitis in a “real world” setting resulted in significant improvement in disease severity and associated symptoms. Tolerability…
